In the race to modernize data operations in clinical research and regulatory submissions, Robotic Process Automation (RPA) powered by rule-based systems has emerged as a dependable and high-impact solution. These systems offer clarity, control, and reproducibility — critical traits for industries like biopharma where regulatory compliance and data integrity are non-negotiable.

Here, we discuss rule-based RPA as the foundation for a scalable and auditable standards automation pipeline.

Rule-based automation: Transparent, trusted, and tunable

Unlike more probabilistic models, rule-based systems operate on deterministic logic. Every output is traceable back to an explicit rule, which enhances trust and simplifies troubleshooting. This transparency is particularly valuable when the processes must be easily explained to stakeholders and auditors.

Key strengths of rule-based RPA include:

Transparency

Each step in the workflow is rule-driven, making the logic easy to inspect, validate, and justify. This ensures regulatory reviewers can clearly understand how data was transformed or outputs generated — vital in submission contexts.

Consistency

Standard rules applied across studies generate consistent outputs. For example, Cytel’s ALPS system creates SDTM and ADaM code from structured specifications, producing reliable results that hold up across different projects and teams.

Customizability

Rule-based systems are modular. Teams can easily adapt existing rules to accommodate study-specific needs without overhauling the entire system. Tools like Prism allow this by applying both generic rules and study-specific layers for enriched metadata processing.

Cytel’s metadata-driven RPA workflow in action

Our internal automation pipeline demonstrates the power of rule-based RPA. It’s built on a modular architecture where each tool performs a specific, rules-driven task:

• ALPS: Converts metadata specifications into ready-to-run SAS code for SDTM and ADaM datasets, reducing manual programming and minimizing error risks.
• Lighthouse: Enables biostatisticians to build mock shells using reusable templates, ensuring consistency in table and listing structures.
• Prism: Extracts metadata from mock shells and transforms it into XML-format ARMs (Analysis Results Metadata), enriching it through rules and generating code for up to 60% of standard safety outputs.
• TAB Macros and CytelDocs: Automate the creation of summary tables and documentation, saving hours of effort and ensuring compliance with standardized formats.

This end-to-end pipeline reduces manual touchpoints, maintains high quality, and boosts team efficiency.

Where generative AI complements RPA

While rule-based systems are ideal for tasks requiring consistency and auditability, generative AI can complement these systems — particularly in areas where variability is acceptable and outputs don’t require deterministic reproducibility. For example, Gen AI can assist with:

• Drafting exploratory narratives or documentation
• Suggesting code for non-critical outputs
• Enhancing user interfaces with intelligent prompts
• Enrich the set of study specific rules to be used

However, these AI-driven capabilities are best applied where hallucinations won’t compromise integrity, and outputs don’t demand rigid consistency.

Business and quality benefits of rule-based RPA

By relying on rule-based RPA for core data workflows, we’ve realized several tangible gains:

• Time efficiency: Standard code is generated automatically, freeing time for custom analysis.
• Reduced redundancy: Developers no longer rewrite common code across projects.
• Improved QA: Outputs are independently validated and built on rigorously tested rule sets.
• Collaboration at scale: Uniform rules simplify onboarding and knowledge transfer.
• Focus on what matters: Teams can concentrate on non-standard elements that require expertise.

Final takeaways

Rule-based RPA systems provide the transparency, structure, and adaptability required for high-stakes data environments. At Cytel, we’ve found them indispensable in our mission to expedite regulatory submissions without compromising on quality or compliance. As AI continues to evolve, generative technologies may enrich this foundation — but rule-based automation remains the core engine that ensures accuracy, accountability, and speed.

Share Via